RACHEL BABIARZ: Open Payments
NPI 1942828736 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,600 in 137 payments from 20 companies in 2025. Trend: 2023 $834 · 2024 $649 · 2025 $2,600
Food & beverage: $2,516Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $434 |
| ABBVIE INC. | 25 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $368 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $279 |
| QOL Medical, LLC | 9 | $174 |
| Ardelyx, Inc. | 7 | $154 |
| Regeneron Healthcare Solutions, Inc. | 4 | $127 |
| Phathom Pharmaceuticals, Inc. | 8 | $112 |
| Exact Sciences Corporation | 3 | $86 |
| Celltrion USA Inc. | 4 | $74 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, RINVOQ, Sucraid, IBSRELA, DUPIXENT, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
